JFG
TAK icon

Jefferies Financial Group’s Takeda Pharmaceutical TAK Stock Holding History

Jefferies Financial Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,654
Closed -$420K – 2037
2026
Q1 		$420K Buy
+22,654
New +$398K ﹤0.01% 1283
2025
Q2 		– Sell
-13,391
Closed -$199K – 1783
2025
Q1 		$199K Buy
+13,391
New +$188K ﹤0.01% 1390
2023
Q4 		– Sell
-76,323
Closed -$1.18M – 1987
2023
Q3 		$1.18M Buy
+76,323
New +$1.18M 0.01% 776

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Jefferies Financial Group's TAK Position: Q2 2026 in Review

Jefferies Financial Group sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 22,654 shares — an estimated $420K sold.

Jefferies Financial Group first reported a position in TAK in Q3 2023 and held it in 3 quarters. The position peaked at $1.18M in Q3 2023. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Jefferies Financial Group reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 22,654 Takeda Pharmaceutical shares in Q2 2026, an estimated $420K.
  • Jefferies Financial Group first reported a position in Takeda Pharmaceutical in Q3 2023 and held it in 3 quarters.
  • Jefferies Financial Group's Takeda Pharmaceutical position peaked at $1.18M in Q3 2023.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.